Introduction
The inducible NO synthase (iNOS) is one of three isoenzymes generating NO and L-citrulline from L-arginine and molecular oxygen. It is now well established that iNOS expression is regulated at the transcriptional and post-transcriptional level (1, 2) . Since the original discovery in macrophages (2, 3) , iNOS expression has been reported for a number of murine cell types and tissues including astrocytes (4) , endothelial cells of the brain (5) , lung epithelial cells (6) , fibroblasts (7) , keratinocytes (KC) (8) and Langerhans cells (LC)/ dendritic cells (9, 10) . The list of agents known to induce iNOS gene expression in vivo and in vitro has also been growing. The best characterized example is the induction of iNOS in murine macrophages by lipopolysaccharide (LPS) and IFN-γ (11) (12) (13) (14) . These two agents have also been shown to induce iNOS mRNA expression in KC and the PAM 212 KC line (8, 15) as well as in LC/dendritic cells (9, 10, 16) .
NO is a multifunctional mediator and may exert beneficial as well as deleterious effects. In low concentrations, NO produces physiological effects such as vasodilatation (17) and neurotransmission (18) . At high concentrations, NO is responsible for the ability of macrophages to destroy certain viruses, bacteria, fungi, eucaryotic parasites and tumor cells (19) (20) (21) . High NO concentrations also inhibit T cell proliferation (22) . Furthermore, several studies suggest a role for NO in tissue injury and autoimmune disease. Progressive insulitis and deletion of pancreatic islet cells in non-obese diabetic mice is correlated with increased expression of iNOS and is abrogated by iNOS inhibitors (23) . NO has been reported to be expressed in the skin in several instances. During Leishmania infection, NO production is pivotal to the inhibition and destruction of the Leishmania parasites in cutaneous lesions and in draining lymph nodes of resistant mice (24) . KC-derived NO production accompanies wound healing (8) . Expression of iNOS has been observed in lesional skin in psoriasis (25) . NO is involved in maintenance of resting blood flow in human skin and in vasodilator responses to local warming or UV B irradiation (26) .
In the present study, we investigated whether iNOS expression is involved in contact hypersensitivity (CHS). CHS responses are mediated by T cells following epicutaneous application of chemically reactive compounds (haptens). During the sensitization phase, hapten-carrying Langerhans cells migrate from the epidermis to draining lymph nodes, where they present hapten-MHC complexes to specific T cells resulting in primary activation of the latter. Primed T cells infiltrate sites of subsequent hapten exposure (challenge phase), where they are induced, following interaction with hapten-presenting cells, to produce pro-inflammatory lymphokines such as IFN-γ. As a result, inflammatory cells are recruited to the site of challenge, where they are responsible for the characteristic lesions.
Methods

Animals
BALB/c Ann mice were bred in our animal facilities from breeding pairs originally obtained from the Zentralinstitut fü r Versuchstierkunde (Hannover, Germany). The mice were used at 2-5 months of age.
mAb
Clone 2G9 (anti-I-A d , I-E d , rat IgG2a) (27) was a kind gift from Dr M. Mohamadzadeh (Department of Dermatology, Mainz, Germany). Anti-macNOS mAb (anti-iNOS, mouse IgG2a) was purchased from Dianova (Hamburg, Germany). Isotype control mAb were obtained from PharMingen (Hamburg, Germany).
Induction and challenge of CHS
Mice were sensitized by applying 17 µl of a 0.4% 2,4-dintrofluorobenzene (DNFB) solution in acetone:olive oil (4:1) to the shaved abdomen on two consecutive days. Three days later, the mice were challenged by applying 8.5 µl DNFB solution on both sides of the right ear. For control, 8.5 µl of acetone:olive oil were applied on both sides of the left ear. Measurements of ear thickness were performed using a micrometer (Mitutoyo, Tokyo, Japan) both before and at the indicated time intervals after challenge. Ear swelling was calculated by subtracting the thickness of the vehicle-challenged contralateral ear (ഛ0.02 mm) from that of the DNFBchallenged ear. Age-matched mice challenged without previous sensitization exhibited an ear swelling ഛ 0.03 mm.
Administration of NO inhibitors
The NO inhibitors aminoguanidine (50 mM in PBS; Alexis, Grü nberg, Germany) and L-NMA (100 mM in PBS), and the stereoisomer D-NMA (100 mM in PBS; both from CalbiochemNovabiochem, Bad Soden, Germany) were administered by intradermal injection of 50 µl aliquots into the DNFB-treated ears. Intradermal injections of 100 µl PBS served as a negative control.
Tissue sections and epidermal sheets
For tissue sections, DNFB-treated and vehicle-treated ears were transferred into 2-butanol and shock-frozen at -80°C. Then, 5 µm cryostat sections were prepared and stained with hematoxylin & eosin according to standard procedures. For preparation of epidermal sheets, ears were split into ventral and dorsal halves using fine forceps. These were incubated for 20 min at 37°C in 0.5 M ammonium thiocyanate in 0.1 M NaKHPO 4 buffer, pH 6.8. Then epidermis and dermis were separated using fine forceps, and the epidermal sheets were fixed for 5 min in 50% acetone:50% ethanol. The sheets were washed 3 times in PBS, kept for 1 h at room temperature, and then incubated overnight with mAb 2G9 and anti-macNOS at an optimal concentration in PBS/4% skimmed milk at 4°C. The sheets were washed 3 times in PBS followed by incubation for 1 h at 37°C with phycoerythrin-labeled goat anti-rat IgG (0.5 µg) and with biotin-conjugated goat anti-mouse IgG (0.5 µg) (both from Dianova). The biotin-conjugated antibody was detected by streptavidin-horseradish peroxidase (1:500) and Fluorescein Tyramide (1:50) using the Tyramide signal amplification kit TSA-Direct (Green) from DuPont NEN (Boston, MA) according to the recommendations of the manufacturer.
Preparation and short-term in vitro culture of epidermal cells
Epidermal cell suspensions were prepared from ears or pelts as described previously (28) . Per mouse, 6-8ϫ10 7 cells (viability Ͼ 85%) were obtained. The epidermal cell suspension was either used directly or was cultivated for 3 days in Iscove's modified Dulbecco's medium (Life Technologies, Eggenstein, Germany) supplemented with 2 mM L-glutamine, 5ϫ10 -5 M 2-mercaptoethanol, 100 IU penicillin, 100 µg/ml streptomycin, 12.5 µg/ml amphotericin B, 500 µg/ml gentamycin and 10% FCS in 175 cm 2 tissue culture flasks (TPP, Trasadingen, Switzerland).
Enrichment of LC
LC were enriched from epidermal cells by immunomagnetic separation with Dynabeads M-450 (Dynal, Hamburg, Germany) as described (29) . Briefly, Dynabeads M-450 coupled with goat anti-rat IgG were loaded with mAb 2G9 for 3 h at 4°C with gentle agitation. Beads were washed 3 times with PBS/2% horse serum and were added to an epidermal cell suspension prepared as outlined above. A ratio of five beads per LC was used. The number of LC in epidermal cell suspensions was estimated at 3% for fresh epidermal cells and 9% for cultured epidermal cells, as shown by cytospin analysis. The mixture of cells (10 8 cells/7 ml PBS/2% horse serum) and beads was incubated for 1 h at 4°C with gentle agitation. Rosetted cells and free beads were separated from non-rosetted cells by placing the tube in a magnetic particle concentrator (Dynal). The non-rosetted cells were removed and the rosetted cells were washed three times with PBS/2% horse serum using the same separation technique. A purity of LC (viability Ͼ 95%) of~92-95% was obtained as determined by the ratio of rosetted to non-rosetted cells.
For selected experiments, LC enriched by magnetic beads were further purified. Using a micromanipulator (Micromanipulator M; Leitz, Wetzlar, Germany), bead-bound LC were visually separated from non-rosetted cells. LC (100% pure), were collected and transferred directly to a tube containing mRNA extraction buffer. 
Cultivation and stimulation of PAM 212 cells
The murine KC cell line PAM 212 (30) was maintained in IMDM with 5% FCS and 2 mM L-glutamine. Following cultivation the supernatant was removed and ice-cold versen (Roth, Karlsruhe, Germany) was added. After 10 min incubation 4°C the cells were harvested. Equal cell numbers (10 6 ) were subjected to incubation at 37°C without further additives or with 0.1-5 µg/ml DNFB (Sigma, Deisenhofen, Germany) in DMSO, 0.1-2 µg/ml Kathon CG (Hermal, Reinbek, Germany) or 100 µg/ml K 2 Cr 2 O 7 (Roth). Cells were used directly for mRNA preparation or, alternatively, cell pellets were shock-frozen in liquid nitrogen and stored at -70°C for later preparation.
mRNA extraction and RT-PCR
mRNA was isolated using the QuickPrep Micro-mRNA purification kit (Pharmacia, Freiburg, Germany) and was resuspended in diethylpyrocarbonate-treated water. The RNA concentration and quality were assessed by performing RT-PCR with β-actin-specific primers and subsequent electrophoresis on non-denaturing vertical 1.4% (w/v) agarose gels. Before starting reverse transcription, mRNA in aqueous solution (3 µl) was denatured at 65°C for 5 min and chilled on ice. A cDNA synthesis mix was added to a final volume of Fig. 7 .. pH 8.3, 1 mM dNTP, 2.5 µM random hexamer primer, 1 U/µl RNase inhibitor and 2.5 U/µl MuLV RT (all reagents for cDNA synthesis were purchased from Perkin-Elmer, Ueberlingen, Germany). The reaction was carried out at 40°C for 15 min, followed by 5 min at 95°C and 5 min at 4°C. The RT reaction mixture was used directly for PCR.
Primers were generated by MWG-Biotech (Ebersberg, Germany). Primers act/1 (GTGGGCCGCTCTAGGCACCA) and act/2 (TAGCCCTCGTAGATGGGCACAG) were chosen to amplify a 403 bp fragment of murine β-actin cDNA. The primers iNOS/1 (AATAGAGGAACATCTGGCCAGG) and iNOS/ 2 (ATGGCCGACCTGATGTTGC) amplify a 258 bp product of murine iNOS. PCR reactions were performed under mineral oil in a total volume of 100 µl. The 20 µl RT reaction mixture was used completely or in part and was brought to 2 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 0.2 mM dNTP and 1.5 mM of each required primer. Amplification was carried out in a Model 480 DNA Thermal Cycler (Perkin-Elmer). Taq DNA polymerase (2.5 U) was added to start the reaction when the reaction mixture had reached 94°C (hot start). The cDNA was amplified in a specified number of cycles with 1 min denaturation at 94°C, 1 min annealing at different temperatures (see below) and 1 min extension at 72°C. Following the specific number of cycles, a final extension was performed for 7 min at 72°C. The annealing temperature was decreased during the first eight cycles (2ϫ69°C, 2ϫ68°C, 2ϫ67°C, 2ϫ66°C) followed by 25 cycles at 65°C to increase specificity (touch down protocol). The PCR products were analyzed on non-denaturing vertical 1.4% (w/v) agarose gels in 1ϫTBE, stained with ethidium bromide and detected under UV light. Fluorescence of the products was detected relative to each other and to the marker fragments, using an imaging system (Herolab, Wiesloch, Germany). For quantitative analysis of the PCR reactions equal amounts of a competitor fragment were added to each PCR reaction as described previously (15) . The competitor fragment (310 bp) is flanked by the primer binding sites for iNOS/1 and iNOS/2, but has no further sequence homology to iNOS.
Statistical analysis
Statistical analysis was performed using the paired Student's t-test.
Results
Intradermal application of the NOS inhibitor L-NMA reduces the CHS response
CHS was induced in BALB/c mice by application of DNFB on two consecutive days onto the shaved abdomen and elicited 3 days later by painting DNFB on the left ear. The inhibitor L-NMA was injected intradermally into the ears on day 1 and day 2 following challenge with DNFB. Control animals were either injected with the stereoisomer D-NMA, or with PBS. D-NMA-treated animals showed no significant difference in ear swelling compared with control animals, whereas animals treated with L-NMA showed a significantly reduced CHS response (Fig. 1A) .
Moreover, a single injection of 50 µl of a 100 mM L-NMA solution was sufficient to significantly reduce CHS. We injected L-NMA at the day of challenge (Fig. 2A) , as well as 1 (Fig.  2B) and 2 (Fig. 2C ) days after challenge. In all cases a weaker CHS response was observed following administration of L-NMA.
On day 3 after elicitation, ear sections were prepared and stained with hematoxylin & eosin. In agreement with the data obtained by measurement of the ear swelling we observed a reduced cell infiltrate in inhibitor-treated animals (Fig. 3B) , as compared with control animals (Fig. 3C) , shown representatively for a mouse treated with L-NMA on day 1 after challenge. 
Reduced CHS response following intradermal injection of the iNOS inhibitor aminoguanidine
BALB/c mice were treated by intradermal injection of 50 µl of 50 mM aminoguanidine that preferentially inhibits murine iNOS (31) , directly prior to elicitation of CHS and again on day 2 after challenge. As a control, mice were treated with 50 µl of 50 mM ammonium acetate. The animals treated with aminoguanidine showed a significantly reduced ear swelling response compared with the controls (Fig. 1B) .
iNOS is expressed by epidermal LC Our data suggest that iNOS contributes to the CHS response. We therefore investigated whether iNOS was expressed in epidermal cells, i.e. in KC and LC. While previous reports indicated that iNOS is produced by murine KC stimulated by cytokines (8, 15) , conflicting results have been reported with regard to iNOS production by LC (10, 32) . RT-PCR was performed with mRNA of freshly isolated and cultured epidermal LC using primers specific for iNOS, which do not amplify mRNA derived from endothelial NOS and neuronal NOS. The primers were selected to amplify a 258 bp product of murine iNOS cDNA according to the sequence data reported by Loewenstein et al. (33) . As the primers are intron-spanning, products derived from cDNA and genomic DNA are distinguishable in size. Clear signals were obtained with both LC populations (Fig. 4) . The amplification of correct fragments was verified by mol. wt estimation on agarose gels, by restriction of the PCR product using an internal BamHI restriction site, and by subcloning and sequencing of the amplified product (not shown). The sequence of the subcloned PCR product was identical with the published sequence (33) .
The LC had been isolated with magnetic beads coupled to anti-MHC class II mAb as outlined above. In order to exclude the possibility that the signals obtained were due to contaminating non-rosetted cells (i.e. KC), we collected rosetted LC by micromanipulation under visual control and subjected these 100% pure rosetted cells to mRNA isolation and RT-PCR. Again a clear signal was detectable (Fig. 4) .
Expression of iNOS mRNA is enhanced in MHC class IIpositive and MHC class II-negative epidermal cells by contact allergen treatment in vivo
BALB/c mice were sensitized twice on the abdomen and challenged on the left ear by epicutaneous application of DNFB as outlined above. Development of a CHS response was verified by measuring the ear thickness of the DNFBtreated left ears and the vehicle-treated right ears 24 h after elicitation. Epidermal cells were separately isolated from DNFB-treated and vehicle-treated ears. mRNA was prepared in parallel from unseparated epidermal cells as well as from MHC class II-positive (LC) and MHC class II-negative cells (mainly KC) and was subjected to competitive RT-PCR (15) . The number of PCR cycles was limited to 25 to ensure the exponential amplification of the template molecules. Unseparated epidermal cells as well as class II-positive and class II-negative cells derived from DNFB-treated ears showed markedly enhanced iNOS mRNA expression compared with cells from the vehicle-treated ears of the same mice. The MHC class II-positive cells representing LC contained especially high levels of iNOS mRNA (Fig. 5) . When PCR was allowed to proceed for 32 cycles, faint bands were visible using the three populations isolated from vehicle-treated ears (data not shown).
iNOS mRNA expression of PAM 212 KC is enhanced by treatment with contact allergens in vitro in a dose-dependent fashion.
DNFB-induced iNOS expression, as shown above, is especially pronounced in MHC class II-positive cells. Therefore the question arose whether KC, other MHC class II-negative epidermal cell populations or contaminating MHC class IIpositive LC were responsible for the augmented iNOS expression in the class II-negative cell population. Thus we investigated the effect of contact allergens on iNOS expression of the murine KC cell line PAM 212 in vitro by RT-PCR. Unstimulated PAM 212 cells produced only small amounts of iNOS mRNA. Application of DNFB increased iNOS expression dose dependently (Fig. 6 ). The concentrations of DNFB used neither impaired the viability of the cells nor their ability to proliferate as shown by incorporation of [ 3 H]thymidine into cellular DNA (data not shown). However, further increases in the DNFB concentration resulted in a reduced viability of the cells as well as in a reduced iNOS expression (data not shown). The contact allergens Kathon CG and K 2 Cr 2 O 7 exhibited a moderate stimulating effect on iNOS mRNA expression (Fig. 6) .
Contact allergen treatment in vivo induced iNOS protein expression in LC
To study the expression of iNOS in epidermal cells on the protein level, epidermal sheets were prepared from DNFBor vehicle-treated ears of sensitized BALB/c mice, and were double-stained with anti-MHC class II and anti-iNOS mAb. In epidermal sheets prepared from vehicle-treated ears the class II-positive LC (Fig. 7C ) did not stain with the anti-iNOS mAb (Fig. 7D) . In contrast, following application of DNFB the class II-positive LC (Fig. 7A ) co-expressed iNOS protein (Fig. 7B) . The staining is clearly visible despite of the swelling of the epidermis. No staining was observed with the isotype controls ( Fig. 7E and F) .
Discussion
The data presented in this report indicate that NO synthesized by cellular NOS is involved in CHS. The ear swelling response was significantly reduced following intradermal application of the inhibitor L-NMA, while the inactive stereoisomer D-NMA had no significant effect. Ear swelling was reduced by a single injection of the inhibitor as late as 1 or 2 days after application of contact allergen.
The results of the inhibition experiments with aminoguanidine suggested that iNOS was largely responsible for NO production during CHS. Aminoguanidine has a marked specificity for iNOS in rodents (31) . Nevertheless, an effect of the inhibitor on the constitutive NOS during CHS cannot be excluded beyond doubt. Use of the recently developed iNOS-deficient mice (34, 35) will allow us to estimate, more accurately, the contribution of iNOS in the course of CHS.
Inhibition of iNOS activity reduced the ear swelling response by about 40%. Although the extent of iNOS inhibition in vivo is not clear, this indicates that NO contributes to the symptoms of CHS. Epicutaneous application of dexamethasone resulted in a Ͼ90% reduction of ear swelling (data not shown). Glucocorticoids have been shown to inhibit the induction of NOS (36) . It is tempting to speculate that part of their potent inhibitory effect on CHS is due to preventing the induction of iNOS, in addition to their inhibitory action on T cells and inflammatory cells.
The induction of iNOS mRNA expression in LC and KC by treatment of mice with contact allergens supports the view that iNOS plays a role in CHS. NO synthesis by IFN-γ-and/ or LPS-activated KC has been previously reported (8, 15) . We observed an increased iNOS mRNA expression not only in freshly isolated MHC class II-negative epidermal cells (mainly KC) after treatment with contact allergen in vivo, but also in PAM 212 cells following treatment with several contact allergens in vitro.
MHC class II-positive LC, isolated from epidermal cell suspensions either shortly after preparation or following a 3 day culture of the epidermal cells, expressed iNOS mRNA. The level was considerably increased in class II-positive cells isolated from the epidermis of contact allergen-treated mice. Induction of iNOS mRNA in purified LC by contact allergens in vitro could not be determined, because the cells do not survive the culture period without the addition of cytokines (granulocyte macrophage colony stimulating factor, tumor necrosis factor-α) which are known to enhance iNOS expression themselves (37, 38) . Thus we cannot discriminate whether iNOS mRNA induction in LC is the result of a direct action of contact allergens on LC or of the action of cytokines elaborated by contact allergen-activated keratinocytes.
The finding of iNOS mRNA expression in freshly isolated LC is in agreement with the recently published data by Qureshi et al. (10) . At first sight our data seem to conflict with results obtained by Blank et al. (32) , who were unable to detect iNOS mRNA expression in LC isolated from IFN-γ/LPSstimulated epidermal cells of untreated mice. In their study LC were collected by single-cell picking on the basis of morphological criteria, i.e. development of dendrites, whereas we selected LC by single-cell picking based on rosetting with anti-MHC class II-coupled beads. It is, therefore, possible that Blank et al. selected for a subpopulation of LC that was negative for iNOS expression. Antibodies to MHC class II molecules were reported to stimulate bone marrow-derived macrophages to NO production (39) , arguing that the LC isolation procedure (rosetting with anti-class II mAb-coupled magnetic beads) induced expression of iNOS mRNA in LC. This appears rather unlikely, however, since the bone marrowderived macrophages were stimulated with the antibody for 24 h at 37°C, whereas the immunomagnetic isolation of LC was performed at 4°C for only a short period of time, immediately followed by mRNA extraction. Moreover, iNOS protein expression in LC was detectable by immunostaining of epidermal sheets, where anti-class II mAb were only applied subsequent to a fixation step. An induction of iNOS expression by trace amounts of LPS in our culture medium is unlikely, as identical results were obtained using LPS-free media.
iNOS has been implicated in tissue damage during acute and chronic inflammation. Cytotoxic and cytostatic effects of NO have been reported (40) . However, the cytotoxic effects require high concentrations of NO. In contrast, low amounts of NO are sufficient to induce vasodilatation and thereby support the infiltration of inflammatory cells into the target tissue. Infiltration of inflammatory cells into the sites of allergen challenge is essential for the development of CHS. As shown here, inhibition of NOS by L-NMA reduced the infiltration of cells into DNFB-challenged ears. Taken together our data suggests that epidermal cell-derived NO contributes to tissue injury in CHS, most likely by an indirect effect on the inflammatory reaction, rather than by a direct cytotoxic effect.
